Trigger Point Massage in Chronic Tension Headache

Tension-Type Headache Clinical Trial

Official title:

Efficacy of Trigger Points Massage in Severity of Chronic Tension Headache:An Unmasked, Randomized, Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04232046
• Other study ID #: 1288
• Status: Completed
• Phase: N/A
• Start date: February 15, 2016
• Est. completion date: March 15, 2019

Study information

• Verified date: January 2020
• Source: Mazandaran University of Medical Sciences
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Patients with IHS criteria of chronic tension headache , considering inclusion and exclusion criteria, enrolled to this study. They will be randomized to intervention or control group by block randomization method, then treat by standard drug( nortriptyline 10 mg daily) or trigger point massage.

They report severity, frequency, duration of headaches and number of analgesic drugs in diary during week 1 and week 4. Then data based on dairy will be analysis.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 80
• Est. completion date: March 15, 2019
• Est. primary completion date: March 15, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

1. Chronic tension type headache according to IHS criteria

2. Finding painful trigger point in physical examination

3. no contraindication for massage

4. no prophylactic treatment

5. written inform consent

Exclusion Criteria:

1. Dementia or severe cognitive impairment

2. Under Treatment with drugs with prophylactic effect

3. History of RA or Cervicocephalic fracture or other skeletal deformity

4. Other complementary treatment

Related Conditions & MeSH terms

• Headache
• Tension-Type Headache

Intervention

Other:
• Massage
Massage the trigger points in 8 different points for 1 min in circle direction and 3 times a day.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Mazandaran University of Medical Sciences

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Headache severity change	By Visual Analogue Scale score,from 0 that indicate no pain to 10 that indicate severe pain	Mean Visual Analogue Scale sore change in week 4 from the baseline
Secondary	Headache frequency change	Number of attacks in week	Change in number of attacks in week 4 from the base line
Secondary	Headache duration change	Time duration ( in minutes)of attacks in week	Change in Time duration in week 4 from the baseline
Secondary	Number of analgesic change	Number of analgesic drugs used during a week	Change in Number of analgesic drugs used in week 4 from the baseline